GB824375A - Respiration-stimulant substances from blood - Google Patents
Respiration-stimulant substances from bloodInfo
- Publication number
- GB824375A GB824375A GB38114/56A GB3811456A GB824375A GB 824375 A GB824375 A GB 824375A GB 38114/56 A GB38114/56 A GB 38114/56A GB 3811456 A GB3811456 A GB 3811456A GB 824375 A GB824375 A GB 824375A
- Authority
- GB
- United Kingdom
- Prior art keywords
- blood
- dialysis
- carbon atoms
- deproteination
- animals
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
Abstract
A process for the preparation of a respiration-stimulating active substance comprises subjecting the blood of slaughter-animals to dialysis to effect substantially complete deproteination and to effect complete removal of protein particles having a molecular weight in excess of approximately 3000 therefrom and concentrating the dialysate thereby obtained to a dry content of 10-60 mg/ml., preferably at least 30 mg/ml. The dialysis is preferably effected in a tube of "Cellophane" (Registered Trade Mark) employing as solvents water or dilute alcohol. Prior to dialysis the blood may be subjected to a preliminary deproteination by fractional precipitation with alcohols, e.g. straight or branched chain aliphatic alcohols containing from 1-6 carbon atoms or acid such as trichloracetic acid or preferably perchloric acid. The concentrated dialysate may be purified by precipitation with aliphatic ketones or alcohols containing from 1-6 carbon atoms, acetone being a particularly useful precipitant, or by extraction with a water-immiscible or partly immiscible solvent such as aliphatic alcohols with 3-8 carbon atoms, e.g. butanol, or aliphatic ethers with 2-12 carbon atoms and both resulting phases worked up. Preferably the blood is subjected to a pretreatment before dialysis or before the preliminary deproteination preceding dialysis, such as haemolysis, treatment with acetone, spray-drying, defibrination, peptic and/or tryptic digestion. The crude concentrate and/or purified concentrate may be evaporated to dryness, dissolved in distilled water and sterile filtered and freeze-dried under sterile conditions. Phenol and cresol may be added as preservatives. The crude concentrate after sterile filtration can be applied directly. The blood used is preferably that of young slaughter-animals and may come from animals which have been put into a condition of altered activity by mechanical or chemical treatment or by irradiation. Blood-cells and plasma may be separated and worked up separately.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE824375X | 1955-12-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB824375A true GB824375A (en) | 1959-11-25 |
Family
ID=6747263
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB38114/56A Expired GB824375A (en) | 1955-12-13 | 1956-12-13 | Respiration-stimulant substances from blood |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB824375A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2022429A1 (en) * | 1968-11-02 | 1970-07-31 | Ist Naz Chim Biolog | |
DE3042999A1 (en) * | 1980-11-14 | 1982-07-22 | Solco Basel AG, Birsfelden | Skin cosmetic compsn. contg. calves blood extract - prepd. by dialysis against water, concn. and inorganic salt extn. by silica gel treatment |
FR2527079A1 (en) * | 1982-05-21 | 1983-11-25 | Solco Basel Ag | PROCESS FOR OBTAINING ACTIVE SUBSTANCES ACCELERATING CELL BREATHING FROM CALF BLOOD |
EP0645135A1 (en) | 1993-09-29 | 1995-03-29 | Solco Basel AG | Sunscreen composition containing hemodialysate |
WO2002067957A1 (en) * | 2001-02-28 | 2002-09-06 | Biopure Corporation | Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier |
US7001715B2 (en) | 2002-02-28 | 2006-02-21 | Biopure Corporation | Purification of red blood cells by separation and diafiltration |
-
1956
- 1956-12-13 GB GB38114/56A patent/GB824375A/en not_active Expired
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2022429A1 (en) * | 1968-11-02 | 1970-07-31 | Ist Naz Chim Biolog | |
DE3042999A1 (en) * | 1980-11-14 | 1982-07-22 | Solco Basel AG, Birsfelden | Skin cosmetic compsn. contg. calves blood extract - prepd. by dialysis against water, concn. and inorganic salt extn. by silica gel treatment |
FR2527079A1 (en) * | 1982-05-21 | 1983-11-25 | Solco Basel Ag | PROCESS FOR OBTAINING ACTIVE SUBSTANCES ACCELERATING CELL BREATHING FROM CALF BLOOD |
EP0095170A2 (en) * | 1982-05-21 | 1983-11-30 | Solco Basel AG | Process for obtaining cellular respiration stimulation-active substances from calves' blood |
GB2130088A (en) * | 1982-05-21 | 1984-05-31 | Solco Basel Ag | Cell stimulating agents |
EP0095170A3 (en) * | 1982-05-21 | 1984-06-06 | Solco Basel Ag | Process for obtaining cellular respiration stimulation-active substances from calves' blood |
EP0645135A1 (en) | 1993-09-29 | 1995-03-29 | Solco Basel AG | Sunscreen composition containing hemodialysate |
US5486353A (en) * | 1993-09-29 | 1996-01-23 | Solco Basel Ag | Antisun product |
WO2002067957A1 (en) * | 2001-02-28 | 2002-09-06 | Biopure Corporation | Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier |
US6518010B2 (en) | 2001-02-28 | 2003-02-11 | Biopure Corporation | Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier |
AU2002250229B2 (en) * | 2001-02-28 | 2004-11-25 | Biopure Corporation | Manufacture of a hemoglobin-based oxygen carrier |
US6986984B2 (en) | 2001-02-28 | 2006-01-17 | Biopure Corporation | Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier |
US7553613B2 (en) | 2001-02-28 | 2009-06-30 | Biopure Corporation | Use of defibrinated blood for manufacture of hemoglobin-based oxygen carrier |
US7001715B2 (en) | 2002-02-28 | 2006-02-21 | Biopure Corporation | Purification of red blood cells by separation and diafiltration |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE53297T1 (en) | PROCESS FOR MANUFACTURING A BIOLOGICALLY ACTIVE EXTRACT. | |
GB824375A (en) | Respiration-stimulant substances from blood | |
Svennerholm | On sialic acid in brain tissue | |
US2134256A (en) | Process of producing and refining organ extracts | |
GROLLMAN et al. | A new procedure for the determination of the antidiuretic principle in the urine | |
EP0110688B1 (en) | Angiogenic factor production | |
Evans et al. | Concentration of the gonadotropic hormone in pregnant mare's serum | |
SU624562A3 (en) | Method of producing substance exhibiting hormonal action | |
US4197238A (en) | Method of preparation of human albumin using polyethylene glycol | |
NZ182682A (en) | Separating iron compounds from protein in blood substance-containing liquid | |
US3472831A (en) | Process for purifying mistletoe proteins by ultracentrifugation | |
Chiba et al. | Stabilization of urinary erythropoietin | |
Ross et al. | Experimental infections of lambs with Trichostrongylus axei; investigations using abomasal cannulae | |
US5711948A (en) | Plant-derived, biologically active polysaccharides and method of preparing same | |
US2594314A (en) | Process for preparing an antipernicious anemia concentrate | |
US3267090A (en) | Viscumic acid and salts thereof | |
US3584123A (en) | Method of treatment of skin diseases and therapeutic products from the roots of securidaca longipedonculata | |
Greene et al. | The preparation of pure d-riboflavin from natural sources | |
US2985561A (en) | Process for the producing of a substance which causes leucocytosis | |
Akama | Chemistry and Biology of Lipids XXI. On Group Lipids from Lungs of Group A and O Persons | |
US2635984A (en) | Process of preparing antigen-rich bacterial toxins and toxoids | |
Holdsworth et al. | Absorption of vitamin B12 from the rat intestine | |
EMMELIN | Ultrafiltration as a Method of Preparing Blood Plasma for Quantitative Estimation of Histamine. | |
JPS5625114A (en) | Preparation of human gamma globulin | |
Giovannini et al. | Different molecular weight of the plasmatic erythropoietin compared with the renal and splenic erythropoietic factors in the rabbit |